Cargando…
Analysis of Septin 9 Gene Hypermethylation as Follow-Up Biomarker of Colorectal Cancer Patients after Curative Surgery
Background: The Septin 9 test analyzes the methylation status of the SEPT9 gene, which appears to be hypermethylated in patients with colorectal cancer (CRC). This has been validated as a colorectal cancer screening test. Due to the high sensitivity and specificity found, the justification was to us...
Autores principales: | Leon Arellano, Miguel, García-Arranz, Mariano, Guadalajara, Héctor, Olivera-Salazar, Rocío, Valdes-Sanchez, Teresa, García-Olmo, Damián |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9024426/ https://www.ncbi.nlm.nih.gov/pubmed/35454041 http://dx.doi.org/10.3390/diagnostics12040993 |
Ejemplares similares
-
A First Step to a Biomarker of Curative Surgery in Colorectal Cancer by Liquid Biopsy of Methylated Septin 9 Gene
por: Leon Arellano, M., et al.
Publicado: (2020) -
KRAS G12V Mutation Detection by Droplet Digital PCR in Circulating Cell-Free DNA of Colorectal Cancer Patients
por: Olmedillas López, Susana, et al.
Publicado: (2016) -
Stem cell therapy applied for digestive anastomosis: Current state and future perspectives
por: Trébol, Jacobo, et al.
Publicado: (2022) -
Differential presence of exons (DPE): sequencing liquid biopsy by NGS. A new method for clustering colorectal Cancer patients
por: Rubio-Mangas, David, et al.
Publicado: (2023) -
The Role of Shared Decision-Making in Personalised Medicine: Opening the Debate
por: Guadalajara, Hector, et al.
Publicado: (2022)